Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 317237011000036112 | prilocaine hydrochloride 0.5% (250 mg/50 mL) injection, 5 x 50 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 317238011000036113 | prilocaine hydrochloride 250 mg / 50 mL injection, 5 x 50 mL vials (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| prilocaine hydrochloride 0.5% (250 mg/50 mL) injection, 5 x 50 mL vials | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| prilocaine hydrochloride 0.5% (250 mg/50 mL) injection, 5 x 50 mL vials | has MPUU | prilocaine hydrochloride 0.5% (250 mg/50 mL) injection, vial | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Citanest (prilocaine hydrochloride 250 mg / 50 mL) injection, 5 x 50 mL vials (trade product pack) | Is a | True | prilocaine hydrochloride 0.5% (250 mg/50 mL) injection, 5 x 50 mL vials | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR